Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Kingfisher’s share price drops more than 5% despite record revenue and profits

Kingfisher’s share price slid today, despite pre-tax profit jumping 33.1% and the company reporting record annual revenue and profits.

Source: Bloomberg

​B&Q owner, Kingfisher did extremely well across the pandemic as it continues to gain market share in both the UK and France, but the company predicted a profit drop after its record year which triggered today’s 5% sell-off.

Kingfisher reported a 9.7% rise in total sales for the year, to £13.2 billion, while pre-tax profit rose 33.1% to £1 billion. The dividend has been lifted to 12.4p per share, up by just over 50%.

Kingfisher’s share price declined by around 30% from its early January high at around the 360 pence mark, having accelerated lower when Russia invaded Ukraine, since the company’s exposure to Poland represents 13% of group sales.

The stock fell to levels last seen in August 2020 at 247.2p as investors worried about Kingfisher’s ability to deliver a strong performance against a backdrop of consumers rotating away from home spend as inflation bites, on top of a weak macro-economic outlook.

The company’s shares did recover in line with most global equity markets, however, as the war in Ukraine takes a back seat.

Source: ProRealTime

In early March, the share price briefly slid through the 200-week simple moving average (SMA) at 255.13p, to the October 2018 and April 2019 highs at 247.2p, before forming a Doji on the weekly candlestick chart.

This has been followed by a bullish candle last week which propelled the share towards the minor psychological 300p mark and the 2022 downtrend line at 304p before today’s sharp sell-off.

The 11 March daily chart Doji low at 267.4p is currently being aimed at. While it isn’t slipped through on a daily chart closing basis, the Kingfisher share price may recover and a gradual advance lasting several weeks could still unfold.

For this to happen, this week’s high at 298.4p and the downtrend line will have to be exceeded.

Source: ProRealTime

If so, the 314p to 317p zone should be next in line but should prove difficult to overcome when first tested as it consists of the October 2020 high and September-to-November 2021 lows.

A rise above the next higher late February high at 326p would push the 200-day SMA at 336.69p to the fore.

Failure at 267.4p would put the 248p early March low back on the cards, a fall through which would have bearish implications with the December 2019 high at 227p being targeted in such a scenario.

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access
Learn more

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off
Log in now

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform
Log in now

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Take advantage

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

<h3>How much does trading cost?</h3>
<h3>Find out about IG</h3>
<h3>Plan your trading</h3>

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.